MEMOPROVE Trademark

Trademark Overview

On Tuesday, September 12, 2006, a trademark application was filed for MEMOPROVE with the United States Patent and Trademark Office. The USPTO has given the MEMOPROVE trademark a serial number of 79030749. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Wednesday, December 12, 2018. This trademark is owned by Ebewe Pharma Ges.m.b.H. Nfg. KG. The MEMOPROVE trademark is filed in the Pharmaceutical Products category with the following description:

[ Pharmaceutical and veterinary preparations used for treatment of cancer, central nervous system diseases, immunological deficiencies and heart and circulatory problems; ] food supplements for medical use
memoprove

General Information

Serial Number79030749
Word MarkMEMOPROVE
Filing DateTuesday, September 12, 2006
Status706 - SECTION 71 ACCEPTED
Status DateWednesday, December 12, 2018
Registration Number3352656
Registration DateTuesday, December 11, 2007
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 25, 2007

Trademark Statements

Goods and Services[ Pharmaceutical and veterinary preparations used for treatment of cancer, central nervous system diseases, immunological deficiencies and heart and circulatory problems; ] food supplements for medical use
Pseudo MarkMEMO PROVE

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 27, 2006
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEVER Neuro Pharma GmbH
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressAT
Party NameEbewe Pharma Ges.m.b.H. Nfg. KG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressAT
Party NameEbewe Pharma Ges.m.b.H. Nfg. KG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressAT
Party NameEbewe Pharma Ges.m.b.H. Nfg. KG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAT

Trademark Events

Event DateEvent Description
Thursday, December 21, 2006ASSIGNED TO EXAMINER
Thursday, November 23, 2006SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Monday, November 27, 2006NEW APPLICATION ENTERED
Saturday, July 7, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 21, 2006NON-FINAL ACTION WRITTEN
Friday, December 22, 2006NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, January 3, 2007REFUSAL PROCESSED BY MPU
Wednesday, January 3, 2007NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, January 18, 2007REFUSAL PROCESSED BY IB
Monday, July 2, 2007TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 2, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 2, 2007TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 2, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, July 10, 2010NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, August 21, 2007ASSIGNED TO LIE
Tuesday, August 21, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, September 5, 2007NOTICE OF PUBLICATION
Tuesday, September 25, 2007PUBLISHED FOR OPPOSITION
Tuesday, December 11, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, March 18, 2008FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, April 2, 2008FINAL DISPOSITION PROCESSED
Wednesday, April 2, 2008FINAL DISPOSITION NOTICE SENT TO IB
Friday, December 19, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, June 11, 2018REGISTERED-SEC.71 FILED
Thursday, June 14, 2018POST REGISTRATION ACTION MAILED - SEC.71
Monday, July 18, 2011CHANGE OF OWNER RECEIVED FROM IB
Monday, December 9, 2013TEAS SECTION 71 & 15 RECEIVED
Monday, December 9, 2013REGISTERED - SEC. 71 & SEC. 15 FILED
Tuesday, December 24, 2013REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Tuesday, December 24, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, December 24, 2013NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Friday, January 2, 2015INTERNATIONAL REGISTRATION RENEWED
Sunday, December 11, 2016COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Monday, June 11, 2018TEAS SECTION 71 RECEIVED
Thursday, February 4, 2021NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, December 11, 2018TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Wednesday, December 12, 2018REGISTERED-SEC.71 ACCEPTED
Wednesday, December 12, 2018NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Monday, August 12, 2019PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Saturday, August 31, 2019INVALIDATION PROCESSED
Saturday, August 31, 2019PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, October 18, 2019PARTIAL INVALIDATION PROCESSED BY THE IB
Thursday, November 21, 2019NEW REPRESENTATIVE AT IB RECEIVED
Thursday, October 17, 2024INTERNATIONAL REGISTRATION RENEWED
Saturday, November 4, 2023NEW REPRESENTATIVE AT IB RECEIVED
Saturday, February 6, 2021CORRECTION TRANSACTION RECEIVED FROM IB
Wednesday, February 17, 2021CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Monday, November 1, 2021NEW REPRESENTATIVE AT IB RECEIVED

Related Keywords

memoprove heart deficiencies immunological circulatory problems medical supplements food diseases system